JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. Financials Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Equities
301093
CNE100004YH2
Tires & Rubber Products
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.26 CNY | -0.60% |
|
+2.92% | -27.99% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 4,380 | 2,991 | - |
| Enterprise Value (EV) 1 | 4,380 | 2,991 | 2,991 |
| P/E ratio | 37.3 x | 17.2 x | 11.1 x |
| Yield | - | - | - |
| Capitalization / Revenue | 7.03 x | 2.7 x | 1.9 x |
| EV / Revenue | 7.03 x | 2.7 x | 1.9 x |
| EV / EBITDA | 21.8 x | 11.7 x | 7.87 x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | 1.76 x | 1.17 x | 1.07 x |
| Nbr of stocks (in thousands) | 135,606 | 128,569 | - |
| Reference price 2 | 32.30 | 23.26 | 23.26 |
| Announcement Date | 4/21/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net sales 1 | 622.9 | 1,107 | 1,571 |
| EBITDA 1 | 200.9 | 256 | 379.8 |
| EBIT 1 | 138.7 | 234.9 | 358.5 |
| Operating Margin | 22.26% | 21.22% | 22.82% |
| Earnings before Tax (EBT) 1 | 137.3 | 208 | 324 |
| Net income 1 | 117.9 | 182 | 283 |
| Net margin | 18.93% | 16.44% | 18.01% |
| EPS 2 | 0.8670 | 1.350 | 2.100 |
| Free Cash Flow | - | - | - |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 4/21/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Debt | - | - | - |
| Net Cash position | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | - | - |
| ROE (net income / shareholders' equity) | 4.82% | 7.52% | 10.5% |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets 1 | - | - | - |
| Book Value Per Share 2 | 18.30 | 19.90 | 21.80 |
| Cash Flow per Share 2 | 1.650 | 1.090 | 1.790 |
| Capex 1 | 297 | 182 | 177 |
| Capex / Sales | 47.65% | 16.43% | 11.28% |
| Announcement Date | 4/21/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.26
CNY
Average target price
43.78
CNY
Spread / Average Target
+88.22%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.99% | 414M | |
| +16.92% | 29.95B | |
| +37.53% | 7.05B | |
| +25.21% | 4.1B | |
| -1.54% | 3.6B | |
| -11.52% | 3.61B | |
| +49.53% | 3.46B | |
| +23.07% | 3.18B | |
| +23.60% | 2.84B | |
| +8.20% | 2.51B |
- Stock Market
- Equities
- 301093 Stock
- Financials Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.